3562 results for «251»

Filter By

3562 results

Rapid-fire - Nightmares in the cathlab - Part 3

21 Nov 2023 – From PCR London Valves 2023

Consult this session to uncover challenging scenarios: navigate the complications of balloon-expanding TAVI embolization triggered by a Starr Edwards valve in the mitral position, delve into the nightmare of an embolic stroke post-TAVI in a patient with a porcelain aorta, explore the complexities of TAVR following two...

Rapid-fire - Nightmares in the cathlab - Part 3

Challenges in TAVIs, are there guideline recommendations?

20 Nov 2023 – From PCR London Valves 2023

The EAPCI consensus session emphasized the critical role of evaluating and managing coronary artery disease in TAVI candidates, especially in younger and lower-risk patients. Transcatheter heart valve choice influences future coronary access, emphasizing the need for optimized implantation techniques. In cardiogenic shock due to valvular heart...

Challenges in TAVIs, are there guideline recommendations?

Newer generation self-expanding platform: technical optimisation for common clinical challenges

05 Dec 2023 – From GulfPCR-GIM 2023

The primary focus of this GulfPCR-GIM 2023 session revolves around pre-procedural planning considerations, valve selection, and managing complex anatomies using both traditional self-expanding valves and the Evolut FX system. Additionally, the session aims to explore the work-up protocol for patients grappling with severe AS and advanced...

Newer generation self-expanding platform: technical optimisation for common clinical challenges

Essentials of lifetime management of TAVR patients using novel Myval THV

05 Dec 2023 – From GulfPCR-GIM 2023

Join this GulfPCR-GIM 2023 session to explore the Myval next-generation THV technology, uncovering its unique features, procedural advantages, and clinical benefits, from extensive patient data. Learn also about the CorAlign technique that ensures precise commissural and coronary alignment while preserving coronary access, and gain insights into...

Essentials of lifetime management of TAVR patients using novel Myval THV

Rapid-fire - Complications of Mitral TEER - Part 1

17 Feb 2024 – From PCR Tokyo Valves 2024

Gain valuable insights into the possible complications of Mitral Transcatheter Edge-to-Edge Repair (TEER) in the first part of this session rapid-fire submission cases. Learn about what might cause a loud rumbling sound after intervention, and explore a rare complication of the MitraClip procedure. 

How to optimise lifetime management of TAVI patients with long life expectancy?

17 Feb 2024 – From PCR Tokyo Valves 2024

In this special session sponsored by Abbott, gain insight into how valve design and features may influence clinical outcomes and future interventions. Learn about hemodynamic efficiency of TAVI valves, and understand the factors influencing durability and clinical performance over time.

TAVI in challenging anatomies

17 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session to learn more about how to manage complex anatomy and complications during TAVI. Learn about successful cases of PTMC and TAVI performed simultaneously, gain insight into TAVI considerations and techniques for a very severely calcified aortic valve, and explore a scientific and safe...

TAVI for patients with concomitant coronary artery disease - LIVE case

17 Feb 2024 – From PCR Tokyo Valves 2024

An 88-year-old male presented a severe symptomatic aortic valve with preserved LV function (64%), a coronary artery disease with a LAD PCI a few years ago and a significant (75%) RCA stenosis with an FFR angio at 0.74. He also has a short membrane septum (2.5...

TAVI for patients with concomitant coronary artery disease - LIVE case

PCR Tokyo Valves 2024 Welcome Ceremony

17 Feb 2024 – From PCR Tokyo Valves 2024

After a brief overview of the Course's history and the success of the PCR Family's various Courses, join the Course Directors as they unveil the new venue for the 2024 edition, introduce the team, and reveal the schedule for three intense days featuring a diverse and...

PCR Tokyo Valves 2024 Welcome Ceremony

Challenges in TEER for secondary mitral regurgitation

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore this session on secondary mitral regurgitation to understand the ideal case predictors gleaned from trials like EVEREST, COAPT, or MITRA-FR, delve into patient selection conundrums, including optimal medical therapy, examine technical challenges posed by atrial functional mitral regurgitation, and gain insights into TEER techniques for...

Challenges in TEER for secondary mitral regurgitation

Valve-in-Valve

17 Feb 2024 – From PCR Tokyo Valves 2024

Discover various compelling cases of valve-in-valve interventions in this session: such as TAVI for a structural valve deterioration with winding snake-like aorta, the uses of tomography-fluoroscopy fusion imaging in bioprosthetic aortic valve cracking, and more!

The optimal first valve choice for patients with aortic stenosis - Key considerations for lifetime management

17 Feb 2024 – From PCR Tokyo Valves 2024

This session tackles the pressing topic of TAVI's success in treating aortic stenosis, particularly in younger patients, and the ensuing questions regarding device durability, potential follow-up procedures, and the interplay between TAVI and surgical options. The aim is to ensure optimal decision-making that prioritizes patient welfare...

The optimal first valve

Rapid-fire - Complications in SHD interventions

17 Feb 2024 – From PCR Tokyo Valves 2024

Learn more about complications related to structural heart disease interventions through this rapid-fire series of cases. Discover cases such as a cardiac arrest due to coronary artery obstruction two days after TAVI using a balloon-expandable valve, an aortic stenosis case switched to surgery due to severe...

Achieving the optimal outcome using the latest self-expandable TAVI - LIVE case

17 Feb 2024 – From PCR Tokyo Valves 2024

An 86-year-old woman presented severe symptomatic aortic stenosis and coronary artery disease with a preserved LV function. The operators performed a PCI of the RCA ostium one month ago. The CT showed a small femoral access (diameter: 5.3 to 4.9 mm). 
After a predilatation with a 20 mm...

Achieving the optimal outcome using the latest self-expandable TAVI - LIVE case

Rapid-fire - Mitral TEER for special situations

17 Feb 2024 – From PCR Tokyo Valves 2024

Gain valuable insights into the possible complications of Mitral Transcatheter Edge-to-Edge Repair (TEER) in the first part of this session rapid-fire submission cases [in Japanese].

Contemporary techniques for TAV-in-SAV interventions

18 Feb 2024 – From PCR Tokyo Valves 2024

Thanks to this session, take a look at the current outcomes of TAV-in-SAV, analyse the different types of valves and their fracturability, find out more, through case studies, about two different TAV-in-SAV techniques, with or without a stent, and learn how to avoid patient prosthesis mismatch...

Contemporary techniques for TAV-in-SAV interventions

Primary mitral regurgitation edge to edge repair with one device - LIVE case

18 Feb 2024 – From PCR Tokyo Valves 2024

An 83-year-old male presented symptomatic severe PMR due to lateral P2 chordal rupture, small LA and preserved LV function (68%). Watch the operators implant one XTW clip successfully.

LIVE case from Sendai Kousei Hospital - Sendai, Japan

 
Navigate the video by moving your mouse over the chapter icon in...

Mitral transcatheter edge to edge repair for a patient with degenerative mitral regurgitation - LIVE case

Shaping the future of structural heart disease intervention

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session if you want to discuss the remaining challenges of transcatheter valvular interventions, and to review latest innovations for structural heart disease.

Shaping the future of structural heart disease intervention

Heart Team in action: managing complex cases together

17 Feb 2024 – From PCR Tokyo Valves 2024

In this group discussion, several heart teams present their work on complex cases of tricuspid valve interventions and explore the results of their collaboration in order to figure out adequate management for invasive treatments. 

Late-Breaking Trial session

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore pivotal findings from registries and studies, including the OCEAN-TAVI Registry on PPM prevalence in Asian TAVR patients, SIL-TAVI Registry insights on TAVI outcomes in cancer patients, the EXPAND G4 study's outcomes for Japanese MitraClip G4 recipients, and TRISTAR study's 30-day results on K-Clip for tricuspid...

Late-Breaking Trial session
Didn’t find what you were looking for?